Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells

The variety of therapies available for treating and preventing triple-negative breast cancer (TNBC) is constrained by the absence of progesterone receptors, estrogen receptors, and human epidermal growth factor receptor 2. Nrf2 (nuclear factor-erythroid 2-related factor), and PD-L1 (program cell dea...

Descripción completa

Detalles Bibliográficos
Autores principales: Adinew, Getinet M., Messeha, Samia S., Taka, Equar, Badisa, Ramesh B., Soliman, Karam F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695946/
https://www.ncbi.nlm.nih.gov/pubmed/36432484
http://dx.doi.org/10.3390/nu14224787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695946/
https://www.ncbi.nlm.nih.gov/pubmed/36432484
http://dx.doi.org/10.3390/nu14224787

Ejemplares similares